BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tee HK, Zainol MI, Sam IC, Chan YF. Recent advances in the understanding of enterovirus A71 infection: a focus on neuropathogenesis. Expert Rev Anti Infect Ther 2021;19:733-47. [PMID: 33183118 DOI: 10.1080/14787210.2021.1851194] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Xie J, Hu X, Li H, Zhu H, Lin W, Li L, Wang J, Song H, Jia L. Murine models of neonatal susceptibility to a clinical strain of enterovirus A71. Virus Res 2023;324:199038. [PMID: 36599394 DOI: 10.1016/j.virusres.2022.199038] [Reference Citation Analysis]
2 Yuan X, Liu Z, Wan L, Liu W, Huang Y, Cao S. Recent advances in anti-coxsackievirus A16 viral drug research. Future Med Chem 2023;15:97-117. [PMID: 36538291 DOI: 10.4155/fmc-2022-0195] [Reference Citation Analysis]
3 Xing J, Wang K, Wang G, Li N, Zhang Y. Recent advances in enterovirus A71 pathogenesis: a focus on fatal human enterovirus A71 infection. Arch Virol 2022;167:2483-501. [PMID: 36171507 DOI: 10.1007/s00705-022-05606-4] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Zhong M, Wang H, Yan H, Wu S, Wang K, Yang L, Cui B, Wu M, Li Y. Effects and mechanism of Aβ1-42 on EV-A71 replication. Virol J 2022;19:151. [PMID: 36127711 DOI: 10.1186/s12985-022-01882-3] [Reference Citation Analysis]
5 Wang J, Hu Y, Zheng M. Enterovirus A71 antivirals: Past, present, and future. Acta Pharmaceutica Sinica B 2022;12:1542-66. [DOI: 10.1016/j.apsb.2021.08.017] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
6 Wang J, Li H. Editorial of Special Column on Antiviral Drug Discovery and Pharmacology. Acta Pharm Sin B 2022;12:1540-1. [PMID: 35474901 DOI: 10.1016/j.apsb.2022.03.005] [Reference Citation Analysis]
7 李 勇. Progress in Diagnosis and Treatment of Enterovirus Encephalitis in Children. ACM 2022;12:3662-3667. [DOI: 10.12677/acm.2022.124530] [Reference Citation Analysis]
8 Yan L, Cao R, Zhang H, Li Y, Li W, Li X, Fan S, Li S, Zhong W. Design, synthesis and evaluation of 2'-acetylene-7-deaza-adenosine phosphoamidate derivatives as anti-EV71 and anti-EV-D68 agents. Eur J Med Chem 2021;226:113852. [PMID: 34560428 DOI: 10.1016/j.ejmech.2021.113852] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Hirschenberger M, Hunszinger V, Sparrer KMJ. Implications of Innate Immunity in Post-Acute Sequelae of Non-Persistent Viral Infections. Cells 2021;10:2134. [PMID: 34440903 DOI: 10.3390/cells10082134] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
10 Hu Y, Kitamura N, Musharrafieh R, Wang J. Discovery of Potent and Broad-Spectrum Pyrazolopyridine-Containing Antivirals against Enteroviruses D68, A71, and Coxsackievirus B3 by Targeting the Viral 2C Protein. J Med Chem 2021;64:8755-74. [PMID: 34085827 DOI: 10.1021/acs.jmedchem.1c00758] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
11 Lee MHP, Tan CW, Tee HK, Ong KC, Sam IC, Chan YF. Vaccine candidates generated by codon and codon pair deoptimization of enterovirus A71 protect against lethal challenge in mice. Vaccine 2021;39:1708-20. [PMID: 33640144 DOI: 10.1016/j.vaccine.2021.02.024] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]